Eckert & Ziegler, EANM announce research awards

Isotope technology firm Eckert & Ziegler and the European Association of Nuclear Medicine (EANM) have named five nuclear medicine specialists as winners of the 2016 Eckert & Ziegler Abstract Award at this week's EANM congress in Barcelona.

The competition, which awards 1,000 euro prizes for research in the oncological diagnostics, was decided by a jury of seven EANM members. This year's award winners were:

  • Francesco Ceci, Italy: Ga-68 PSMA PET/CT for early restaging prostate cancer. Preliminary results of a prospective trial in patients with biochemical failure after radical therapy and PSA levels < 2 ng/mL
  • Francesco Cicone, Italy: Value of F-DOPA PET in the long-term follow-up of radionecrotic brain metastases after radiosurgery: comparison with MRI
  • Sandra Heskamp, the Netherlands: SPECT/CT imaging of the PD-1/PD-L1 immune checkpoint pathway in syngeneic murine tumor models
  • Egesta Lopci, Italy: Prognostic significance of molecular and imaging biomarkers in primary brain tumors
  • Bogdan Mitran, Sweden: Feasibility of in vivo imaging of VEGFR2 expression using high affinity antagonistic biparatopic affibody construct ZVEGFR2-Bp2

The winners were selected from a total of 717 entries, according to Eckert & Ziegler.

Page 1 of 114
Next Page